{"CONCEPT_ID":[19080226],"CDM_TABLE_NAME":["DRUG_ERA"],"CONCEPT_NAME":["milnacipran"],"NUM_PERSONS":[1],"PERCENT_PERSONS":["0.0006"],"RECORDS_PER_PERSON":[" 1.0"],"AGE_AT_FIRST_EXPOSURE":[{"CATEGORY":"FEMALE","MIN_VALUE":42,"P10_VALUE":42,"P25_VALUE":42,"MEDIAN_VALUE":42,"P75_VALUE":42,"P90_VALUE":42,"MAX_VALUE":42}],"PREVALENCE_BY_GENDER_AGE_YEAR":[{"TRELLIS_NAME":"40-49","SERIES_NAME":"FEMALE","X_CALENDAR_YEAR":2021,"Y_PREVALENCE_1000PP":26.3158}],"PREVALENCE_BY_MONTH":[{"X_CALENDAR_MONTH":202102,"Y_PREVALENCE_1000PP":3.2468}],"LENGTH_OF_ERA":[{"CATEGORY":"Length of Era","MIN_VALUE":0,"P10_VALUE":0,"P25_VALUE":0,"MEDIAN_VALUE":0,"P75_VALUE":0,"P90_VALUE":0,"MAX_VALUE":0}]}
